The relationship of medical comorbidity and depression in older, primary care patients.
Jeffrey M Lyness, Aurelian Niculescu, Xin Tu...
https://pubmed.ncbi.nlm.nih.gov/16959933Actively Recruiting
Led by University of Southern California · Updated on 2025-11-25
120
Participants Needed
2
Research Sites
N/A
Total Duration
U
University of Southern California
Lead Sponsor
N
National Institute of Mental Health (NIMH)
Collaborating Sponsor
Researchers are studying the factors that contribute to cognitive impairment and faster cognitive decline in people with Late Life Depression (LLD). This observational research aims to understand these changes without providing treatment. The study began in 2015, initially enrolling 133 participants, and will continue by enrolling 120 participants over 30 months, including both continuing participants and new enrollees. Data from 300 non-depressed individuals will be used for comparison. Participants with Major Depression or Late Life Depression will be followed without treatment. Assessments will include magnetic resonance imaging (MRI) scans and positron emission tomography (PET) scans for amyloid and tau proteins. Blood samples will be collected for genetic and biomarker analysis. Clinical and cognitive tests will be done at two time points during the study. Participants will undergo evaluations including depression history, symptom severity, and health information at the start. They will have brain scans and blood drawn at specified visits. Researchers will measure changes in memory, executive function, language skills, brain structure, and protein deposits over five years. Genetic studies using collected data will also be conducted. The study is planned to continue through May 2027.
CONDITIONS
Characterizing Cognitive Decline in Late Life Depression: The ADNI Depression Project
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 5 years
Participants undergo assessments including neuropsychological tests, MRI scans, and biomarker measurements to characterize cognitive decline.
Regular assessments during the 5-year period
Duration - 5 years
Participants are monitored over time to track changes in cognitive function and brain structure.
Periodic visits for follow-up assessments during the 5-year period
Total: 2 locations
1
University of California, San Francisco
San Francisco, California, United States, 94143
Actively Recruiting
2
University of Pittsburgh
Pittsburgh, Pennsylvania, United States, 15213
Completed
N
Nithya Ganesh
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Jeffrey M Lyness, Aurelian Niculescu, Xin Tu...
https://pubmed.ncbi.nlm.nih.gov/16959933Jane McCusker, Martin Cole, Antonio Ciampi...
https://pubmed.ncbi.nlm.nih.gov/17591511T Gabryelewicz, M Styczynska, E Luczywek...
https://pubmed.ncbi.nlm.nih.gov/17136705Michael A Rapp, Denis Gerstorf, Hanfried Helmchen...
https://pubmed.ncbi.nlm.nih.gov/18827231L Ganzini, D M Smith, D S Fenn...
https://pubmed.ncbi.nlm.nih.gov/9063276